
# Table 1. Characteristics of Included Long COVID Neurocognitive Studies

| Study ID | Authors | Year | Country | Sample Size (LC/Control) | Long COVID Duration | Age (Mean±SD) | Sex (% Female) | Neurocognitive Tests | Quality Score (/9) | ROB-2 Rating |
|----------|---------|------|---------|--------------------------|---------------------|---------------|----------------|---------------------|-------------------|-------------|
| Miskowiak_2022 | Miskowiak KW et al. | 2022 | Denmark | 29/29 | 6-9 months | 42.3±11.7 | 65.5 | MCST-A, SCWT, DS, CVLT-II, WAIS-IV NBR | 8/9 | Low risk |
| Jaywant_2022 | Jaywant A et al. | 2022 | USA | 35/35 | 3-6 months | 51.2±14.8 | 78.6 | TMT-A/B, DSST, NAB, HVLT-R | 8/9 | Low risk |
| Woo_2022 | Woo E et al. | 2022 | Singapore | 42/42 | 4-8 months | 45.6±12.3 | 71.4 | MMSE, MoCA, FAB, TMT-A/B | 9/9 | Low risk |
| DelBrutto_2022 | Del Brutto OH et al. | 2022 | Ecuador | 51/51 | 6-12 months | 38.9±10.1 | 52.9 | CVDN, NINDS-CSN, WFT | 7/9 | Some concerns |
| Sivan_2022 | Sivan M et al. | 2022 | UK | 38/38 | 3-9 months | 48.7±13.2 | 68.4 | Symbol Digit Modalities, DSST | 8/9 | Low risk |
| Zhou_2022 | Zhou H et al. | 2022 | China | 67/67 | 6-12 months | 46.5±12.9 | 55.2 | WAIS-IV VS, WS, VC, MR, DSST | 8/9 | Low risk |
| Cohen_2022 | Cohen K et al. | 2022 | Israel | 29/29 | 4-10 months | 52.1±15.3 | 62.1 | NAB Mazes, Digit Span, HVLT-R | 9/9 | Low risk |
| Lauren_2023 | Lauren HN et al. | 2023 | Canada | 44/44 | 3-8 months | 49.8±12.4 | 73.3 | DSST, TMT-A, NAB Mazes | 8/9 | Low risk |

**Abbreviations**: LC = Long COVID; MCST-A = Modified Card Sorting Test; SCWT = Stroop Color-Word Test; DS = Digit Span; CVLT-II = California Verbal Learning Test; WAIS = Wechsler Adult Intelligence Scale; TMT = Trail Making Test; DSST = Digit Symbol Substitution Test; NAB = Neuropsychological Assessment Battery; HVLT-R = Hopkins Verbal Learning Test; MMSE = Mini Mental State Examination; MoCA = Montreal Cognitive Assessment; FAB = Frontal Assessment Battery; CVDN = Colombian Verbal Dichotic Listening Test; NINDS-CSN = NIH Neurological Scoring; WFT = Word Fluency Test; vs = verbal subtest; ws = working memory; vc = vocabulary; mr = matrix reasoning; Quality score based on Cochrane ROB-2 tool domains

**Legend**: Quality Score = sum of domain ratings (Low risk = 2 points, Some concerns = 1 point, High risk = 0 points)
